130 filings
Page 5 of 7
DEFA14A
mhbd7c7jfi
26 Apr 22
Additional proxy soliciting materials
4:57pm
DEF 14A
d9h7bw4
26 Apr 22
Definitive proxy
4:55pm
S-8
qqg2ophlf3vtdmgk5
24 Mar 22
Registration of securities for employees
5:26pm
S-8
ck0agy93bfewhxbc4ls
24 Mar 22
Registration of securities for employees
5:24pm
10-K
scpg 5gjbfq
24 Mar 22
Annual report
5:18pm
8-K
m788uw
24 Mar 22
Company builds out management team and continues to implement its clinical programs to advance much-needed technologies for women’s health
4:24pm
8-K
bg2i6bw 5irs
28 Feb 22
Disrupting Convention in Women’s Health Through Continuous Innovation February 2022 Corporate Presentation 1
8:53am
8-K
2nuy1hf2pryon2
24 Feb 22
Femasys Inc. Announces the Appointment of Dov Elefant to New Position of Chief Financial Officer
9:16am
8-K
944ju5fq
20 Jan 22
Femasys Inc. Announces the Appointment of Wendy Perrow, Transformational Biotech Entrepreneur, as New Board Member
9:11am
8-K
z16y2suk b4
5 Jan 22
Disrupting Convention in Women’s Health Through Continuous Innovation January 2022 Corporate Presentation
6:45am
8-K
mdzwgs8bi3fn8
10 Nov 21
Femasys Inc. Announces Financial Results for the Third Quarter of 2021
4:01pm
8-K
0ehtrjngjbvvshg l34
20 Sep 21
Other Events
4:41pm
8-K
zpxlg9 oodmn
1 Sep 21
Femasys Inc. Announces the Appointment of Edward Evantash, M.D. as Chief Medical Officer
5:18pm
10-Q
ipwaels wd4
11 Aug 21
Quarterly report
4:58pm
8-K
84w9uw5lnarq1j7
11 Aug 21
Femasys Inc. Announces Financial Results for the Second Quarter of 2021
4:45pm
8-K
84ahg
20 Jul 21
Femasys Inc. Announces First Patient Treated in Pivotal Trial for FemaSeed
8:56am
8-K
azwr56 fwa7bgcmwzvs
13 Jul 21
Transforming Women’s Healthcare ©2021 Femasys Inc. Corporate PresentationJuly 2021
8:01am
S-8
0tlnmoc0ztjqln6rkhb
22 Jun 21
Registration of securities for employees
4:49pm
8-K
dp4b35 szg1h24dfhpnf
22 Jun 21
Amendments to Articles of Incorporation or Bylaws
4:23pm